Malaysia
· Delayed Price · Currency is MYR UMediC Group Berhad Statistics
Total Valuation
UMediC Group Berhad has a market cap or net worth of MYR 222.48 million. The enterprise value is 210.63 million.
| Market Cap | 222.48M |
| Enterprise Value | 210.63M |
Important Dates
The next estimated earnings date is Monday, December 2, 2024.
| Earnings Date | Dec 2, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
UMediC Group Berhad has 373.91 million shares outstanding.
| Shares Outstanding | 373.91M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 23.73% |
| Owned by Institutions (%) | 4.60% |
| Float | 92.87M |
Valuation Ratios
The trailing PE ratio is 24.79 and the forward PE ratio is 17.76.
| PE Ratio | 24.79 |
| Forward PE | 17.76 |
| PS Ratio | 4.08 |
| PB Ratio | 3.09 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.36, with an EV/FCF ratio of -106.11.
| EV / Earnings | 23.44 |
| EV / Sales | 3.86 |
| EV / EBITDA | 15.36 |
| EV / EBIT | 18.77 |
| EV / FCF | -106.11 |
Financial Position
The company has a current ratio of 8.25, with a Debt / Equity ratio of 0.01.
| Current Ratio | 8.25 |
| Quick Ratio | 5.82 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.06 |
| Debt / FCF | -0.44 |
| Interest Coverage | 82.49 |
Financial Efficiency
Return on equity (ROE) is 13.64% and return on invested capital (ROIC) is 9.96%.
| Return on Equity (ROE) | 13.64% |
| Return on Assets (ROA) | 8.99% |
| Return on Capital (ROIC) | 9.96% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.70 |
| Inventory Turnover | 2.36 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -20.67% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -20.67% |
| 50-Day Moving Average | 0.61 |
| 200-Day Moving Average | 0.66 |
| Relative Strength Index (RSI) | 45.02 |
| Average Volume (20 Days) | 112,520 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, UMediC Group Berhad had revenue of MYR 54.57 million and earned 8.99 million in profits. Earnings per share was 0.02.
| Revenue | 54.57M |
| Gross Profit | 22.67M |
| Operating Income | 11.22M |
| Pretax Income | 12.64M |
| Net Income | 8.99M |
| EBITDA | 13.59M |
| EBIT | 11.22M |
| Earnings Per Share (EPS) | 0.02 |
Balance Sheet
The company has 13.51 million in cash and 876,000 in debt, giving a net cash position of 12.63 million or 0.03 per share.
| Cash & Cash Equivalents | 13.51M |
| Total Debt | 876,000 |
| Net Cash | 12.63M |
| Net Cash Per Share | 0.03 |
| Equity (Book Value) | 72.77M |
| Book Value Per Share | 0.19 |
| Working Capital | 43.40M |
Cash Flow
In the last 12 months, operating cash flow was 4.32 million and capital expenditures -6.31 million, giving a free cash flow of -1.99 million.
| Operating Cash Flow | 4.32M |
| Capital Expenditures | -6.31M |
| Free Cash Flow | -1.99M |
| FCF Per Share | -0.01 |
Margins
Gross margin is 41.54%, with operating and profit margins of 20.56% and 16.47%.
| Gross Margin | 41.54% |
| Operating Margin | 20.56% |
| Pretax Margin | 23.17% |
| Profit Margin | 16.47% |
| EBITDA Margin | 24.90% |
| EBIT Margin | 20.56% |
| FCF Margin | -3.64% |
Dividends & Yields
UMediC Group Berhad does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 4.03% |
| FCF Yield | -0.89% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
UMediC Group Berhad has an Altman Z-Score of 18.27.
| Altman Z-Score | 18.27 |
| Piotroski F-Score | n/a |